JPMorgan Chase and Co Raised Syngenta to Neutral from Underweight - price target raised to SF370 from SF240
- Firm believes management is likely to consider methods to improve equity return profile of Syngenta as a standalone business for its shareholders
- Firm notes that the main options open to syngenta appears as; a sale/de-emphasis of the American corn and soybean seeds businesses, a re-allocation of capital into shareholder returns or an acquisition in Syngenta’s ‘core’ business areas in due course, and an acceleration of cost cutting
- Firm factors in a 50% probability that the company will be acquired at SF500 in firm's DCF model